Fig. 4.
Changes in patient-reported outcomes after one month in EC-MPS converted and MMF continued group. (A) changes in GSRS subscale (B) changes in GIQLI subscale scores.
*denotes P values <0.05. EC-MPS converted group significantly improved in GSRS and GIQLI all subscale scores compared to MMF continued group.
EC-MPS, enteric-coated mycophenolate sodium; MMF, mycophenolate mofetil; GSRS, Gastrointestinal Symptom Rating Scale; GIQLI, Gastrointestinal Quality of Life Index.